Avisar Limited Filleted accounts for Companies House (small and micro)

Avisar Limited Filleted accounts for Companies House (small and micro)


3 false false false false false false false false false true false false false false false false No description of principal activity 2021-08-01 Sage Accounts Production Advanced 2021 - FRS102_2021 21,189 15,837 803 16,640 4,549 5,352 2,169,967 1,098,581 506,794 2,761,754 2,761,754 2,169,967 xbrli:pure xbrli:shares iso4217:GBP 05892721 2021-08-01 2022-07-31 05892721 2022-07-31 05892721 2021-07-31 05892721 2020-08-01 2021-07-31 05892721 2021-07-31 05892721 core:FurnitureFittings 2021-08-01 2022-07-31 05892721 bus:Director2 2021-08-01 2022-07-31 05892721 core:FurnitureFittings 2021-07-31 05892721 core:FurnitureFittings 2022-07-31 05892721 core:WithinOneYear 2022-07-31 05892721 core:WithinOneYear 2021-07-31 05892721 core:ShareCapital 2022-07-31 05892721 core:ShareCapital 2021-07-31 05892721 core:RetainedEarningsAccumulatedLosses 2022-07-31 05892721 core:RetainedEarningsAccumulatedLosses 2021-07-31 05892721 core:CostValuation core:Non-currentFinancialInstruments 2021-07-31 05892721 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2022-07-31 05892721 core:DisposalsRepaymentsInvestments core:Non-currentFinancialInstruments 2022-07-31 05892721 core:CostValuation core:Non-currentFinancialInstruments 2022-07-31 05892721 core:Non-currentFinancialInstruments 2022-07-31 05892721 core:Non-currentFinancialInstruments 2021-07-31 05892721 core:FurnitureFittings 2021-07-31 05892721 bus:SmallEntities 2021-08-01 2022-07-31 05892721 bus:AuditExempt-NoAccountantsReport 2021-08-01 2022-07-31 05892721 bus:FullAccounts 2021-08-01 2022-07-31 05892721 bus:SmallCompaniesRegimeForAccounts 2021-08-01 2022-07-31 05892721 bus:PrivateLimitedCompanyLtd 2021-08-01 2022-07-31
COMPANY REGISTRATION NUMBER: 05892721
Avisar Limited
Filleted Unaudited Financial Statements
31 July 2022
Avisar Limited
Statement of Financial Position
31 July 2022
2022
2021
Note
£
£
£
Fixed assets
Tangible assets
5
4,549
5,352
Investments
6
2,761,754
2,169,967
------------
------------
2,766,303
2,175,319
Current assets
Stocks
1,275
1,725
Debtors
7
80,718
87,072
Cash at bank and in hand
706,270
592,081
---------
---------
788,263
680,878
Creditors: amounts falling due within one year
8
1,049,323
339,207
------------
---------
Net current (liabilities)/assets
( 261,060)
341,671
------------
------------
Total assets less current liabilities
2,505,243
2,516,990
------------
------------
Capital and reserves
Called up share capital
100
100
Profit and loss account
2,505,143
2,516,890
------------
------------
Shareholders funds
2,505,243
2,516,990
------------
------------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 July 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Avisar Limited
Statement of Financial Position (continued)
31 July 2022
These financial statements were approved by the board of directors and authorised for issue on 30 October 2023 , and are signed on behalf of the board by:
P. Rothem
Director
Company registration number: 05892721
Avisar Limited
Notes to the Financial Statements
Year ended 31 July 2022
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Hallswelle House, 1 Hallswelle Road, London, NW11 ODH.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures & fittings
-
15% reducing balance
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received. Government grants are recognised using the accrual model and the performance model. Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable. Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset. Under the performance model, where the grant does not impose specified future performance-related conditions on the recipient, it is recognised in income when the grant proceeds are received or receivable. Where the grant does impose specified future performance-related conditions on the recipient, it is recognised in income only when the performance-related conditions have been met. Where grants received are prior to satisfying the revenue recognition criteria, they are recognised as a liability.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2021: 4 ).
5. Tangible assets
Fixtures and fittings
Total
£
£
Cost
At 1 August 2021 and 31 July 2022
21,189
21,189
--------
--------
Depreciation
At 1 August 2021
15,837
15,837
Charge for the year
803
803
--------
--------
At 31 July 2022
16,640
16,640
--------
--------
Carrying amount
At 31 July 2022
4,549
4,549
--------
--------
At 31 July 2021
5,352
5,352
--------
--------
6. Investments
Other investments other than loans
£
Cost
At 1 August 2021
2,169,967
Additions
1,098,581
Disposals
( 506,794)
------------
At 31 July 2022
2,761,754
------------
Impairment
At 1 August 2021 and 31 July 2022
------------
Carrying amount
At 31 July 2022
2,761,754
------------
At 31 July 2021
2,169,967
------------
Included within the Investments of the company were shares costing £2,511,764 (2021 £1,903,543). The market value of these investments as at 31st July 2022 was £2,093,461 (2021 £3,115,063).
7. Debtors
2022
2021
£
£
Trade debtors
54,661
45,971
Other debtors
26,057
41,101
--------
--------
80,718
87,072
--------
--------
8. Creditors: amounts falling due within one year
2022
2021
£
£
Trade creditors
42,185
7,942
Corporation tax
38,502
33,543
Other creditors
968,636
297,722
------------
---------
1,049,323
339,207
------------
---------
9. Related party transactions
The company was under the control of Mr P.Rothem throughout the current and previous year. Mr Rothem is the managing director and majority shareholder. No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 8.